Sun Pharma Advanced Research Company Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 211.8 million. Revenue was INR 296.7 million. Net loss was INR 864.2 million. Basic loss per share from continuing operations was INR 2.66.
For the six months, sales was INR 451.3 million. Revenue was INR 638.1 million. Net loss was INR 1,817.7 million. Basic loss per share from continuing operations was INR 5.6.